ARCHIVES

FDA Approves Bexxar For Non-Hodgkin’s Lymphoma

This article is from The Cancer Letter archive.

Vol. 26 No. 6 | June 27, 2003

Download PDF Visit The Full Archive

Related Articles

ACOS Survey To Assess Tumor Boards’ Impact On Patient Care

January 24, 1986

In Brief: Sullivan Will Be Secretary Most Knowledgeable About Cancer Program; Ihde Names ‘JNCI’ Editor

January 6, 1989

FDA Approves DNA Test For Two Types of HPV

March 27, 2009

DCE Board Delays Decision On New Collaborative Groups In Chemoprevention

November 30, 1984

Cancer Center Directors Say Collaboration, Funding, and Application of Best Practices Will Reduce the Burden of Cancer.

September 15, 2006

NCI Advisors: Resume Prevention Trial, Add Edometrial Sampling

May 13, 1994